default author photo

Sudong Liang

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

87

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Discovery of a Highly Potent, Selective, and Stable D-Amino Acid-Containing Peptide Inhibitor of Cdk9/Cyclin T1 Interaction for the Treatment of Prostate Cancer

Number of pages: 25 Posted: 21 Nov 2024
Zhen Xu, Yifei Geng, Lixia Guan, Miao-Miao Niu, Cen Xu, Li Yang and Sudong Liang
affiliation not provided to SSRN, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 54 (1,020,567)

Abstract:

Loading...

CDK9-cyclin T1, Protein-protein interaction (PPI), D-amino acid-containing peptide inhibitor, Prostate cancer (PCa), Structure-based virtual screening

2.

A novel lncRNA HUDRPC suppresses ferroptosis via the DDX5/DDIT3 pathway to promote docetaxel resistance in prostate cancer

Number of pages: 69 Posted: 26 Dec 2025
Sudong Liang, Yuanji Zheng, Xiaobo Wu, Furong Ji, Mierzhayiti Batuer, Qipeng Li, Zengke Qiu, Kaiwen Liu, Li Yang, Qingyi Zhu and jianzhong lin
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 33 (1,277,121)

Abstract:

Loading...

LncRNA, Docetaxel, prostate cancer, Ferroptosis, Resistance